Edwards Lifesciences (EW) PT Lowered to $98 at Evercore ISI
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Edwards Lifesciences (EW) Down on Earnings Miss as Hospital Staffing 'Remains Uncertain'
July 29, 2022 1:32 PM EDTEdwards Lifesciences (NYSE: EW) shares have fallen over 6% Friday on the back of its earnings release.
The company reported after the close Thursday, missing earnings and revenue expectations.
Edwards Lifesciences reported earnings of $0.63, $0.01 worse than the analyst estimate of $0.64 on revenue of $1.37 billion, missing the consensus estimate of $1.4 billion.
The company said it experienced persistent disruption within the healthcare... More



